Van­qua rais­es $45M; Aerovate to look for strate­gic al­ter­na­tives

Plus, news about GSK, iTeos, Ox­o­life and Small­Cel­la:

Van­qua Bio reels in $45M: The Chica­go neu­ro­science biotech ex­tend­ed its Se­ries B, a spokesper­son con­firmed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.